Liver Damage After SJS: California Claim Proof Guide

What this guide covers (and why proof can be complicated after SJS)

SJS is a rare, serious reaction (most often to medications) that can involve the skin/mucosa and systemic complications. Because patients are frequently exposed to multiple medications around the same period (before and during hospitalization), the causation record can become contested. General clinical overviews describe SJS as potentially severe and systemic (see https://www.ncbi.nlm.nih.gov/books/NBK459323/).

When liver injury occurs during or after SJS, common proof issues include (1) multiple possible culprit drugs, (2) evolving liver patterns over time, and (3) the need to evaluate other plausible causes of abnormal liver tests or liver failure. Drug-induced liver injury (DILI) references emphasize careful history, exclusion of competing causes, and attention to timing and lab trends (see https://www.ncbi.nlm.nih.gov/books/NBK548241/).

Key case-theory options in California (high-level overview)

The best legal theory depends on the facts and defendants involved. In broad terms, cases sometimes proceed as:

• Product-related claims: Allegations that a prescription or over-the-counter product triggered SJS and related liver injury (often focusing on warnings, labeling, and whether the product was a substantial factor in harm).
• Healthcare-related claims: Allegations that prescribing, monitoring, diagnosis, delayed drug discontinuation, or other care fell below the standard of care and worsened hepatic outcomes.
• Combined narratives: Allegations that a drug triggered SJS while later care issues contributed to the severity or permanence of liver injury.

Because each pathway involves different rules (and sometimes different procedural hurdles), it is typically worth mapping potential defendants early.

Proof pillar #1: Medication and exposure timeline

A persuasive presentation usually starts with a clean, record-supported timeline showing what was taken (or administered), when doses changed, and when symptoms and abnormal labs emerged. DILI guidance highlights the importance of timing (latency), dechallenge (improvement after stopping a suspected drug), and a complete medication/supplement history (see https://www.ncbi.nlm.nih.gov/books/NBK548241/).

Records that often carry weight

• Pharmacy dispensing records (all fills/refills; include multiple pharmacies if used).
• Hospital medication administration record (MAR) and inpatient medication lists.
• Discharge summary and after-visit summaries noting started/stopped meds.
• Photos of pill bottles/packaging (lot numbers if available).

Practical point: Memory-based reconstructions can be challenged. Pharmacy and MAR documentation is often more reliable for dates, doses, and stop orders.

Proof pillar #2: Medical causation (linking SJS, treatment course, and liver injury)

Causation is often the main dispute. A strong medical causation file typically shows what alternative causes were evaluated and why a drug reaction (and/or complications from severe systemic illness) is the best explanation. Standard DILI references emphasize structured evaluation, including exclusion of viral hepatitis and other liver diseases, and careful analysis of lab patterns and timing (see https://www.ncbi.nlm.nih.gov/books/NBK548241/).

Helpful medical documentation

• Workup for alternative causes: hepatitis testing, autoimmune markers, imaging, and other evaluations as clinically indicated.
• Lab trends over time: AST/ALT, alkaline phosphatase, bilirubin, INR, albumin, platelets (trend format can be especially helpful).
• Specialist consults: dermatology, hepatology, infectious disease, ICU notes.
• Pathology: biopsy reports (and, when feasible, slide retention information).

What decision-makers often look for: a documented differential diagnosis, temporal fit, evidence of improvement after stopping a suspected agent (when applicable), and consistent treating-physician impressions regarding suspected adverse drug reaction.

Proof pillar #3: Severity, permanence, and functional impact

Beyond proving that liver injury occurred, claims often turn on severity and what limitations persist. Evidence may include hospitalization/ICU details, complications (for example, coagulopathy or encephalopathy), ongoing hepatology monitoring, repeat imaging, and documentation of functional restrictions.

• Acute severity: length of hospitalization, ICU care, transfusions/procedures, documented acute liver failure concerns.
• Long-term course: repeated abnormal labs, persistent symptoms (fatigue, cognitive changes), medication restrictions, and ongoing specialist care.
• Prognosis: notes addressing recovery expectations, chronic liver disease risk, cirrhosis concerns, or transplant evaluation (if applicable).

If symptoms fluctuate, consistent follow-up records plus a symptom log can help show day-to-day impact over time.

Proof pillar #4: Damages documentation

Even with strong medical proof, cases generally require organized documentation of losses.

• Medical costs: itemized bills, insurance EOBs, receipts for prescriptions, travel, and medical supplies.
• Future care: expected follow-up testing, imaging, specialist visits, and monitoring.
• Income loss: pay stubs, W-2/1099s, employer attendance records, disability paperwork, or business records for self-employed individuals.
• Out-of-pocket expenses: caregiving, home assistance, transportation.
• Non-economic impact: pain, discomfort, anxiety around medications, sleep disruption, reduced quality of life, and (when relevant) skin/ocular sequelae of SJS.

Common defenses (and the kinds of proof that can help address them)

• Alternative causation: defense may point to viral hepatitis, autoimmune disease, alcohol-related injury, ischemia, sepsis, or another medication. Helpful proof often includes a documented differential diagnosis and appropriate exclusion workup (see https://www.ncbi.nlm.nih.gov/books/NBK548241/).
• Multiple possible culprit drugs: helpful proof often includes a precise MAR/pharmacy timeline and expert analysis of timing and known reaction profiles.
• Pre-existing liver disease: helpful proof often includes baseline labs/records and documentation showing new injury or clear worsening.
• Warning/learned intermediary issues (product cases): helpful proof often includes what warnings existed at the time, what the prescriber knew, and what counseling/monitoring occurred.

Timing and notice in California (why quick review matters)

California filing and notice rules vary by claim type and facts. For example, many personal-injury actions have a two-year limitations period (see https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=CCP&sectionNum=335.1), many medical malpractice actions have a specialized limitations rule (see https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=CCP&sectionNum=340.5), and claims involving public entities can require a pre-suit government claim within shorter timeframes (see https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=GOV&sectionNum=911.2). These rules have exceptions and can turn on accrual/discovery and other case-specific details.

Separately, prompt record preservation can reduce disputes over missing medication records, lab histories, and consult notes.

When to talk to a lawyer (practical triggers)

• A clinician documented suspected drug-induced SJS and/or suspected DILI.
• You were hospitalized/ICU or had sustained abnormal liver labs after SJS.
• You have persistent symptoms, work limitations, or ongoing hepatology care.
• You started multiple new medications shortly before symptom onset.
• You have significant expenses, missed work, or lasting complications.

CTA: If you want help identifying the most important records and next steps, you can contact our office.

FAQ

Do I need a definitive diagnosis of drug-induced liver injury to bring a California claim?

Not always. Many cases turn on whether the evidence shows a medication (or care related to prescribing/monitoring) was a substantial factor in causing or worsening the liver injury, supported by records, timing, and an alternative-cause workup.

What if I was on multiple medications around the time SJS started?

This is common. A pharmacy/MAR-based timeline, treating-physician impressions, and specialist analysis of latency and lab patterns often become central to sorting out likely culprits.

What is the fastest way to strengthen my proof file?

Request the complete hospital chart (including the MAR) and lab trends, then assemble a single timeline that links medications, symptom onset, and key lab changes.

How long do I have to file in California?

Deadlines depend on the claim type and facts, and may be shorter in cases involving public entities. A prompt, individualized review is important to avoid missing a notice or filing requirement.

Sources

• StatPearls (NCBI Bookshelf): Stevens-Johnson Syndrome
• NIH LiverTox (NCBI Bookshelf): Clinical Course and Diagnosis of Drug-Induced Liver Injury
• California Legislative Information: Cal. Code Civ. Proc. § 335.1
• California Legislative Information: Cal. Code Civ. Proc. § 340.5
• California Legislative Information: Cal. Gov. Code § 911.2